SCHEMBL5869321

SCHEMBL5869321

CC(C)CC(NC(Cc1cn(Cc2ccccc2)c2ccccc12)C(=O)O)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.57
ADAM17 P78536 6/20 0.52
HDAC1 Q13547 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
MMP2 P08253 1/20 0.47
MMP13 P45452 1/20 0.47
MMP14 P50281 1/20 0.47
POLB P06746 2/20 0.47
CHRNB2 P17787 1/20 0.47
CHRNA7 P36544 1/20 0.47
CHRNA4 P43681 1/20 0.47
CYP19A1 P11511 1/20 0.47
FNTA P49354 1/20 0.47
FNTB P49356 1/20 0.47
ALDH1A1 P00352 2/20 0.47
LMNA P02545 1/20 0.47
USP2 O75604 1/20 0.46
HSD17B10 Q99714 1/20 0.46
HTR6 P50406 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5869325 1.00 KMT2A (0.57) KMT2AADAM17HDAC1HDAC8HDAC6
SCHEMBL5869335 1.00 KMT2A (0.57) KMT2AADAM17HDAC1HDAC8HDAC6
SCHEMBL5870548 1.00 KMT2A (0.57) KMT2AADAM17HDAC1HDAC8HDAC6
SCHEMBL5869329 1.00 KMT2A (0.57) KMT2AADAM17HDAC1HDAC8HDAC6
SCHEMBL5869442 0.92 ACE2 (0.58) KMT2AADAM17MMP2MMP13MMP14
SCHEMBL5869434 0.92 ACE2 (0.58) KMT2AADAM17MMP2MMP13MMP14
SCHEMBL5869426 0.92 ACE2 (0.58) KMT2AADAM17MMP2MMP13MMP14
SCHEMBL12583691 0.82 KMT2A (0.56) KMT2AADAM17HDAC1HDAC8HDAC6
SCHEMBL9584477 0.81 KMT2A (0.55) KMT2AADAM17HDAC1HDAC8HDAC6
Water SCHEMBL9584808 0.81 KMT2A (0.54) KMT2AADAM17HDAC1HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7045532-B2 ACE-2 modulating compounds and methods of use thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2006-05-16 US disclosed
US-20040082496-A1 ACE-2 modulating compounds and methods of use thereof MILLENNIUM PHARMACEUTICALS, INC. 2004-04-29 US disclosed
WO-2002039997-A2 ACE-2 MODULATING COMPOUNDS AND USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-05-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082496-A1 ACE-2 modulating compounds and methods of use thereof ACE, ACE2, AGTR2 KMT2A 1880/4885ADAM17 705/4885HDAC1 236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.